Listen in as a general cardiologist, surgeon, and interventionalist delve into the latest evidence—including the Evolut™ TAVR 5-Year Low Risk data and SMART Trial 2-Year update—to guide appropriate treatment decisions for patients with severe symptomatic aortic stenosis.
Duke University Health System has integrated Barostim into its comprehensive heart failure program. For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is a device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Listen in as an advanced heart failure specialist discusses patient selection and post-implant management, the implant procedure, patient care pathways, and how Duke has incorporated Barostim into their system.
The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.
Diagnosing female patients with coronary artery disease (CAD) has many challenges. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating these difficulties, and the guidelines and pathways that help with diagnosis and management of women with suspected CAD.
Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.
Growth seeded the need for a dedicated PCI program at Saratoga Hospital that went live in January along with a complete technology overhaul: cath lab, echo, hemodynamic monitoring and a fully integrated cardiovascular information system. The PCI program, close to 100 interventions later, is considered a jewel of the county. It also is a model for other facilities needing a technology refresh.
Creating the structured cardiac cath lab procedure report is the first step to improving patient care and data accuracy, coordinating intraprocedure workflow across the clinical team, making registry reporting seamless, and reducing overall cost of care.
Listen to Dr. Mani Vannan of Piedmont Heart Institute in Atlanta for a discussion on 3D transesophageal echocardiography. It's quick, just 12 minutes, and sure to make you want to take a closer look at 3D TEE.
Listen to David O. Williams, MD, of Brigham & Women's Hospital and Kalon K.L. Ho, MD, MSc of Beth Israel Deaconess Medical Center as they discuss the role of IT in cardiovascular care in patient management, cost containment, workflow, best practices and reporting.
Dr. Michael Pfeiffer, a cardiologist and assistant professor of medicine at Penn State Hershey Heart and Vascular Institute in Hershey, Pa. discusses the advantages of 3D volume echocardiography in the right heart.
Join Connie Ryan, Cardiology Resource Manager at Oklahoma State University Medical Center as she shares how OSUMC was successful in enhancing their physicians workflow and in increasing productivity in their echo lab with the GE Healthcare's Centricity Cardio Enterprise Solution (CCE).